Home Newsfeeds JP Morgan Downgrades Bioventus to Underweight

JP Morgan Downgrades Bioventus to Underweight

JP Morgan analyst Robbie Marcus downgrades Bioventus (NASDAQ:BVS) from Overweight to Underweight.

byBenzinga Newsdesk

November 9, 2022

1 minute read

JP Morgan analyst Robbie Marcus downgrades Bioventus (NASDAQ:BVS) from Overweight to Underweight.

VinFast Forecasts Continued EV Sales To Founder Pham Nhat Vuong’s Ride Service Through 2024: Report

By Nabaparna Bhattacharya

October 19, 8:12 AM

Vietnam-based EV maker VinFast Auto Ltd. (NASDAQ: VFS) reportedly predicts electric car and scooter sales to an affiliated ride service owned by its founder, Pham Nhat Vuong

VFS

Trinity Capital Inc. Provides $12M Growth Capital To Delphinus Medical Technologies, Inc.

By Happy Mohamed

August 22, 9:05 AM

Trinity Capital Inc. (NASDAQ:TRIN) ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth-stage companies, today announced the commitment of $12

TRIN

Constellation Brands Q2 Earnings Top Estimates

By Shivani Kumaresan

October 6, 10:29 AM

Constellation Brands Inc (NYSE:STZ) reported second-quarter FY23 net sales growth of 12% year-on-year to $2.65 billion, beating the consensus of $2.51…

STZ

Biden Administration Unveils $285M Funding For Semiconductor Institute

By Shivani Kumaresan

May 6, 1:40 PM

President Biden's administration initiates a $285 million federal fund to pioneer a digital twin technology institute for semiconductors. This step, in line with the Chips and Science Act, aims to bolster US chip technology, reducing reliance on global supply chains.

AMD

JP Morgan Downgrades Bioventus to Underweight

Related Posts

VinFast Forecasts Continued EV Sales To Founder Pham Nhat Vuong’s Ride Service Through 2024: Report

Trinity Capital Inc. Provides $12M Growth Capital To Delphinus Medical Technologies, Inc.

Constellation Brands Q2 Earnings Top Estimates

Biden Administration Unveils $285M Funding For Semiconductor Institute